GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0K9E) » Definitions » YoY Rev. per Sh. Growth

Novartis AG (LTS:0K9E) YoY Rev. per Sh. Growth : 11.52% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Novartis AG YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Novartis AG's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 11.52%.

Novartis AG's Revenue per Share for the three months ended in Sep. 2024 was $6.50.

Novartis AG YoY Rev. per Sh. Growth Historical Data

The historical data trend for Novartis AG's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG YoY Rev. per Sh. Growth Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.73 3.53 -10.47 1.67 12.75

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.81 11.73 13.13 12.22 11.52

Novartis AG YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Novartis AG's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(22.304-19.782)/ | 19.782 |
=12.75 %

Novartis AG's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(6.498-5.827)/ | 5.827 |
=11.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Novartis AG's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0K9E) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XSWX:ROG XSWX:COPN LLY OCSE:NOVO B JNJ ABBV MRK LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN
Traded in Other Exchanges
NVSEF:USA NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines